scholarly journals Early release of constricting amniotic band of the lower limb follwed by reconstruction using multiple Z-plasty

2021 ◽  
pp. 102054
Author(s):  
Fatimah I. Alabdrabalnabi ◽  
Ayman S. Elsaid ◽  
Fatimah M. Alsinan ◽  
Hasan A. Almushrif ◽  
Mohammed A. Nasr ◽  
...  
Keyword(s):  
Lower Limb ◽  
Amniotic Band ◽  
Early Release

Limb Body Wall Complex and Sirenomelia in Twins

1994 ◽  
Vol 43 (1-2) ◽  
pp. 126-126
Author(s):  
R. Russo ◽  
R. Vecchione
Keyword(s):  
Lower Limb ◽  
Similar Pattern ◽  
Body Wall ◽  
Twin Pair ◽  
Urogenital Tract ◽  
Limb Defects ◽  
Amniotic Band ◽  
Limb Anomalies ◽  
Urogenital Anomalies

AbstractThe coexistence of Limb body wall complex (LBWC) and Sirenomelia sequence (SS) is present in only two studies in the literature on the topic. Tang et al (1991) and Martinez-Frias et al (1992) examined single fetuses and pointed out that the association of these two phenomena is extremely rare. The present study further contributes to the investigation and description of this particular association in a pair of twins. Both twins presented abdominal defects, urogenital anomalies and persistence of the primitive cloaca, but did not show craniofacial (CF) defects or amniotic band related defects. One twin had one leg only. In a previous study on LBWC we identified two morphologically and pathogenetically different phenotypes which, among other characteristics, are identifiable by the presence or absence of CF defects. (Russo et al. 1993; Russo et al. in press). Our twin pair belongs to the LBWC group without CF defects. This group, like SS cases, is usually characterized by the presence of lower limb anomalies. Aside from this, they also share a similar pattern of anomalies involving the urogenital tract and the cloaca. Analysis of the anomalies present in the twin pair leads us to suggest that the Sirenomelia pattern might be at the extreme end in a spectrum of lower limb defects within the LBWC group that does not present CF defects. In brief, we suggest that the coexistence of this LBWC type and SS is not related to the occurrence of two different defects but is the consequence of a common maldevelopmental process occurring during blastogenesis.

The chronically ischemic lower limb

JAMA ◽  
1966 ◽  
Vol 197 (11) ◽  
pp. 915-916
Author(s):  
I. J. Schatz
Keyword(s):  
Lower Limb

Cardiac troponin I in patients with acute upper and lower limb ischemia

VASA ◽  
2008 ◽  
Vol 37 (4) ◽  
pp. 327-332 ◽  
Author(s):  
Koutouzis ◽  
Sfyroeras ◽  
Moulakakis ◽  
Kontaras ◽  
Nikolaou ◽  
...  
Keyword(s):  
Upper Limb ◽  
Lower Limb ◽  
Cardiac Troponin ◽  
Cardiac Involvement ◽  
Troponin I ◽  
Limb Ischemia ◽  
Elevated Troponin ◽  
Troponin Elevation ◽  
Lower Limb Ischemia ◽  
Ischemia Group

Background: The aim of this study was to investigate the presence, etiology and clinical significance of elevated troponin I in patients with acute upper or lower limb ischemia. The high sensitivity and specificity of cardiac troponin for the diagnosis of myocardial cell damage suggested a significant role for troponin in the patients investigated for this condition. The initial enthusiasm for the diagnostic potential of troponin was limited by the discovery that elevated cardiac troponin levels are also observed in conditions other than acute myocardial infarction, even conditions without obvious cardiac involvement. Patients and Methods: 71 consecutive patients participated in this study. 31 (44%) of them were men and mean age was 75.4 ± 10.3 years (range 44–92 years). 60 (85%) patients had acute lower limb ischemia and the remaining (11; 15%) had acute upper limb ischemia. Serial creatine kinase (CK), isoenzyme MB (CK-MB) and troponin I measurements were performed in all patients. Results: 33 (46%) patients had elevated peak troponin I (> 0.2 ng/ml) levels, all from the lower limb ischemia group (33/60 vs. 0/11 from the acute upper limb ischemia group; p = 0.04). Patients with lower limb ischemia had higher peak troponin I values than patients with upper limb ischemia (0.97 ± 2.3 [range 0.01–12.1] ng/ml vs. 0.04 ± 0.04 [0.01–0.14] ng/ml respectively; p = 0.003), higher peak CK values (2504 ± 7409 [range 42–45 940] U/ml vs. 340 ± 775 [range 34–2403] U/ml, p = 0.002, respectively, in the two groups) and peak CK-MB values (59.4 ± 84.5 [range 12–480] U/ml vs. 21.2 ± 9.1 [range 12–39] U/ml, respectively, in the two groups; p = 0.04). Peak cardiac troponin I levels were correlated with peak CK and CK-MB values. Conclusions: Patients with lower limb ischemia often have elevated troponin I without a primary cardiac source; this was not observed in patients presenting with acute upper limb ischemia. It is very important for these critically ill patients to focus on the main problem of acute limb ischemia and to attempt to treat the patient rather than the troponin elevation per se. Cardiac troponin elevation should not prevent physicians from providing immediate treatment for limb ischaemia to these patients, espescially when signs, symptoms and electrocardiographic findings preclude acute cardiac involvement.

Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis – case report and systematic review of dabigatran use

VASA ◽  
2020 ◽  
pp. 1-6 ◽  
Author(s):  
Marina Di Pilla ◽  
Stefano Barco ◽  
Clara Sacco ◽  
Giovanni Barosi ◽  
Corrado Lodigiani
Keyword(s):  
Systematic Review ◽  
Case Report ◽  
Lower Limb ◽  
Limb Ischemia ◽  
Acute Limb Ischemia ◽  
Review Of The Literature ◽  
Heparin Induced Thrombocytopenia ◽  
Lower Limb Ischemia ◽  
Vein Thrombosis ◽  
Left Lower Limb

Summary: A 49-year-old man was diagnosed with pre-fibrotic myelofibrosis after acute left lower-limb ischemia requiring amputation and portal vein thrombosis. After surgery he developed heparin-induced thrombocytopenia (HIT) with venous thromboembolism, successfully treated with argatroban followed by dabigatran. Our systematic review of the literature supports the use of dabigatran for suspected HIT.

Sign in / Sign up

Export Citation Format

Share Document